The genetics of Parkinson's disease and implications for clinical practice

JO Day, S Mullin - Genes, 2021 - mdpi.com
The genetic landscape of Parkinson's disease (PD) is characterised by rare high penetrance
pathogenic variants causing familial disease, genetic risk factor variants driving PD risk in a …

Physical therapist management of Parkinson disease: a clinical practice guideline from the American Physical Therapy Association

JA Osborne, R Botkin, C Colon-Semenza… - Physical …, 2022 - academic.oup.com
A clinical practice guideline on Parkinson disease was developed by an American Physical
Therapy Association volunteer guideline development group that consisted of physical …

Neuroprotective effects of coffee bioactive compounds: a review

K Socała, A Szopa, A Serefko, E Poleszak… - International journal of …, 2020 - mdpi.com
Coffee is one of the most widely consumed beverages worldwide. It is usually identified as a
stimulant because of a high content of caffeine. However, caffeine is not the only coffee …

Gut microbiota: a novel therapeutic target for Parkinson's disease

M Zhu, X Liu, Y Ye, X Yan, Y Cheng, L Zhao… - Frontiers in …, 2022 - frontiersin.org
Parkinson's disease (PD) is the second most common neurodegenerative disease
characterized by motor dysfunction. Growing evidence has demonstrated that gut dysbiosis …

Artificial intelligence within the interplay between natural and artificial computation: Advances in data science, trends and applications

JM Górriz, J Ramírez, A Ortiz, FJ Martinez-Murcia… - Neurocomputing, 2020 - Elsevier
Artificial intelligence and all its supporting tools, eg machine and deep learning in
computational intelligence-based systems, are rebuilding our society (economy, education …

[HTML][HTML] MPTP-induced mouse model of Parkinson's disease: A promising direction for therapeutic strategies

M Mustapha, CNM Taib - Bosnian journal of basic medical …, 2021 - ncbi.nlm.nih.gov
Among the popular animal models of Parkinson's disease (PD) commonly used in research
are those that employ neurotoxins, especially 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine …

Olfactory dysfunction in aging and neurodegenerative diseases

X Dan, N Wechter, S Gray, JG Mohanty… - Ageing research …, 2021 - Elsevier
Alterations in olfactory functions are proposed to be early biomarkers for neurodegeneration.
Many neurodegenerative diseases are age-related, including two of the most common …

Perspective of artificial intelligence in healthcare data management: A journey towards precision medicine

NS Gupta, P Kumar - Computers in Biology and Medicine, 2023 - Elsevier
Mounting evidence has highlighted the implementation of big data handling and
management in the healthcare industry to improve the clinical services. Various private and …

Preventing Parkinson's disease: an environmental agenda

BR De Miranda, SM Goldman… - Journal of …, 2022 - content.iospress.com
Fueled by aging populations and continued environmental contamination, the global burden
of Parkinson's disease (PD) is increasing. The disease, or more appropriately diseases …

Metabolomics of sebum reveals lipid dysregulation in Parkinson's disease

E Sinclair, DK Trivedi, D Sarkar, C Walton-Doyle… - Nature …, 2021 - nature.com
Parkinson's disease (PD) is a progressive neurodegenerative disorder, which is
characterised by degeneration of distinct neuronal populations, including dopaminergic …